Pharmacovigilance system in Eurasian Economic Union
The article deals with the main provisions of the basic document - «Rules of good practice of pharmacovigilance of the Eurasian economic Union», which regulates the study and prevention of adverse reactions and other problems associated with drugs in the member States of the Union, including the Rus...
Saved in:
Main Authors: | I. L. Asetskaya (Author), S. K. Zyryanov (Author), A. S. Kolbin (Author), D. Yu. Belousov (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences between the European and Eurasian Good Pharmacovigilance Practices
by: A. V. Matveev, et al.
Published: (2021) -
Projecting cardiovascular deaths averted due to trans fat policies in the Eurasian Economic Union
by: Matthias Rieger, et al.
Published: (2023) -
Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union
by: A. A. Leshkevich, et al.
Published: (2020) -
Transition to the Non-Clinical Drug Development Principles and Rules of the Eurasian Economic Union: Changes, Challenges, and Prospects
by: A. A. Spasov
Published: (2023) -
That Eurasian
by: Bey, Aleph